These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9129144)

  • 61. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
    Menko FH; Nooy MA; Vasen HF
    Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
    [No Abstract]   [Full Text] [Related]  

  • 62. The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline.
    Yang AS; Gonzalgo ML; Zingg JM; Millar RP; Buckley JD; Jones PA
    J Mol Biol; 1996 May; 258(2):240-50. PubMed ID: 8627622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Germline p53 mutation presenting as synchronous tumors.
    Cavalier ME; Davis MM; Croop JM
    J Pediatr Hematol Oncol; 2005 Aug; 27(8):441-3. PubMed ID: 16096528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
    Moore SK; Zambrano N; Lynch HT; Lipkin M; Kopelovich L
    Cancer Genet Cytogenet; 1996 Sep; 90(2):125-9. PubMed ID: 8830720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A method for detection of germinal mutations in the p53 tumor suppressor gene].
    Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P
    Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Functional screening of p53 status in tumor cells using Saccharomyces cerevisiae].
    Jia LQ; Ishioka C; Osada M; Gamo M; Shimodaira H; Suzuki T; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):466-70. PubMed ID: 9063485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Orbital rhabdomyosarcoma in Li-Fraumeni syndrome.
    Chong DY; Demirci H; Ronan SM; Flint A; Elner VM
    Arch Ophthalmol; 2007 Apr; 125(4):566-9. PubMed ID: 17420382
    [No Abstract]   [Full Text] [Related]  

  • 69. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
    Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
    Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Radiation-induced intracranial osteosarcoma after radiation for acute lymphocytic leukemia associated with Li-Fraumeni syndrome].
    Yoshimura J; Natsumeda M; Nishihira Y; Nishiyama K; Saito A; Okamoto K; Takahashi H; Fujii Y
    No Shinkei Geka; 2013 Jun; 41(6):499-505. PubMed ID: 23732761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene.
    Kikuchi T; Rempel SA; Rutz HP; de Tribolet N; Mulligan L; Cavenee WK; Jothy S; Leduy L; Van Meir EG
    Cancer Res; 1993 Mar; 53(5):957-61. PubMed ID: 8439970
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The molecular biology of childhood rhabdomyosarcoma.
    Parham DM
    Semin Diagn Pathol; 1994 Feb; 11(1):39-46. PubMed ID: 7911248
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors.
    Liu FS; Ho ES; Chen JT; Shih RT; Yang CH; Shih A
    Cancer; 1995 Jul; 76(2):291-5. PubMed ID: 8625105
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors.
    Gutiérrez MI; Bhatia KG; Barreiro C; Spangler G; Schvartzmann E; Muriel FS; Magrath IT
    Hum Mol Genet; 1994 Dec; 3(12):2247-8. PubMed ID: 7881428
    [No Abstract]   [Full Text] [Related]  

  • 75. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
    Diller L; Sexsmith E; Gottlieb A; Li FP; Malkin D
    J Clin Invest; 1995 Apr; 95(4):1606-11. PubMed ID: 7706467
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel p53 splicing site mutation in Li-Fraumeni-like syndrome with osteosarcoma.
    Sakurai N; Iwamoto S; Miura Y; Nakamura T; Matsumine A; Nishioka J; Nakatani K; Komada Y
    Pediatr Int; 2013 Feb; 55(1):107-11. PubMed ID: 23409989
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
    Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
    Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correction: a Li-Fraumeni syndrome p53 mutation.
    Malkin D; Friend SH
    Science; 1993 Feb; 259(5097):878. PubMed ID: 8438145
    [No Abstract]   [Full Text] [Related]  

  • 79. Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma.
    Sameshima Y; Akiyama T; Mori N; Mizoguchi H; Toyoshima K; Sugimura T; Terada M; Yokota J
    Biochem Biophys Res Commun; 1990 Dec; 173(2):697-703. PubMed ID: 2175605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inactivation of the p53 gene expression by a splice donor site mutation in a human T-cell leukemia cell line.
    Soudon J; Caron de Fromentel C; Bernard O; Larsen CJ
    Leukemia; 1991 Oct; 5(10):917-20. PubMed ID: 1961027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.